{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:55:40Z","timestamp":1784649340388,"version":"3.55.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["37 (1676)17\/EMR-II"],"award-info":[{"award-number":["37 (1676)17\/EMR-II"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.abb.2021.109077","type":"journal-article","created":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T19:14:06Z","timestamp":1635621246000},"page":"109077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Inhibition and disruption of amyloid formation by the antibiotic levofloxacin: A new direction for antibiotics in an era of multi-drug resistance"],"prefix":"10.1016","volume":"714","author":[{"given":"Asra Nasir","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insaf Ahmed","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umar Khalid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4037-5857","authenticated-orcid":false,"given":"Vladimir N.","family":"Uversky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9965-8982","authenticated-orcid":false,"given":"Rizwan Hasan","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abb.2021.109077_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cbpa.2018.05.018","article-title":"Therapeutic strategies for targeting neurodegenerative protein misfolding disorders","volume":"44","author":"Scannevin","year":"2018","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.abb.2021.109077_bib2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10930-020-09946-5","article-title":"Bioactive phytocompounds: anti-amyloidogenic effects against hen egg-white lysozyme aggregation","volume":"40","author":"Chowdhury","year":"2021","journal-title":"Protein J."},{"key":"10.1016\/j.abb.2021.109077_bib3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1021\/jz4027612","article-title":"Amyloid fibrils: formation, polymorphism, and inhibition","volume":"5","author":"H\u00e4rd","year":"2014","journal-title":"J. Phys. Chem. Lett."},{"key":"10.1016\/j.abb.2021.109077_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cbpa.2017.06.008","article-title":"Small molecule probes of protein aggregation","volume":"39","author":"Young","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.abb.2021.109077_bib5","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.3390\/ijms19092677","article-title":"Targeting amyloid aggregation: an overview of strategies and mechanisms","volume":"19","author":"Giorgetti","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.abb.2021.109077_bib6","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160101","article-title":"Mechanisms for the inhibition of amyloid aggregation by small ligands","volume":"36","author":"Ramazzotti","year":"2016","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.abb.2021.109077_bib7","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1111\/j.1742-4658.2005.05024.x","article-title":"Aspects on human amyloid forms and their fibril polypeptides","volume":"272","author":"Westermark","year":"2005","journal-title":"FEBS J."},{"key":"10.1016\/j.abb.2021.109077_bib8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/jamaneurol.2013.1453","article-title":"Mechanisms of protein seeding in neurodegenerative diseases","volume":"70","author":"Walker","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.abb.2021.109077_bib9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/713610448","article-title":"Antimicrobial properties of lysozyme in relation to foodborne vegetative bacteria","volume":"29","author":"Masschalck","year":"2003","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.abb.2021.109077_bib10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/362553a0","article-title":"Human lysozyme gene mutations cause hereditary systemic amyloidosis","volume":"362","author":"Pepys","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.abb.2021.109077_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2796.2011.02470.x","article-title":"Hereditary lysozyme amyloidosis -- phenotypic heterogeneity and the role of solid organ transplantation","volume":"272","author":"Sattianayagam","year":"2012","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.abb.2021.109077_bib12","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1046\/j.1523-1755.2003.00904.x","article-title":"A novel lysozyme mutation Phe57Ile associated with hereditary renal amyloidosis","volume":"63","author":"Yazaki","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.abb.2021.109077_bib13","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1523-1755.2002.00205.x","article-title":"Hereditary renal amyloidosis caused by a new variant lysozyme W64R in a French family","volume":"61","author":"Valleix","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.abb.2021.109077_bib14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/13506129.2020.1720637","article-title":"Lysozyme amyloid: evidence for the W64R variant by proteomics in the absence of the wild type protein","volume":"27","author":"Moura","year":"2020","journal-title":"Amyloid"},{"key":"10.1016\/j.abb.2021.109077_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1098\/rstb.2000.0766","article-title":"Pathogenesis, diagnosis and treatment of systemic amyloidosis","volume":"356","author":"Pepys","year":"2001","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.abb.2021.109077_bib16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.revmed.2018.08.008","article-title":"L\u2019amylose \u00e0 lysozyme","volume":"40","author":"Scafi","year":"2019","journal-title":"Rev. Med. Interne"},{"key":"10.1016\/j.abb.2021.109077_bib17","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s00709-020-01513-0","article-title":"Renal amyloidosis: an update on diagnosis and pathogenesis","volume":"257","author":"Gupta","year":"2020","journal-title":"Protoplasma"},{"key":"10.1016\/j.abb.2021.109077_bib18","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1007\/s10067-017-3839-7","article-title":"Hereditary lysozyme amyloidosis with sicca syndrome, digestive, arterial, and tracheobronchial involvement: case-based review","volume":"36","author":"Benyamine","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.abb.2021.109077_bib19","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1016\/j.febslet.2012.09.037","article-title":"Inhibition of amyloid fibrillation of lysozyme by phenolic compounds involves quinoprotein formation","volume":"586","author":"Feng","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.abb.2021.109077_bib20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.sbi.2014.12.004","article-title":"Inhibition of protein aggregation and amyloid formation by small molecules","volume":"30","author":"Doig","year":"2015","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.abb.2021.109077_bib21","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid \u03b2 oligomers and fibrils, binds plaques, and reduces amyloid in vivo","volume":"280","author":"Yang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2021.109077_bib22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12035-010-8111-y","article-title":"Resveratrol as a therapeutic agent for neurodegenerative diseases","volume":"41","author":"Sun","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.abb.2021.109077_bib23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12263-009-0143-4","article-title":"Neuroprotective molecular mechanisms of (\u2212)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties","volume":"4","author":"Weinreb","year":"2009","journal-title":"Genes Nutr"},{"key":"10.1016\/j.abb.2021.109077_bib24","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1021\/acsomega.0c05788","article-title":"Inhibition of lysozyme amyloid fibrillation by silybin diastereoisomers: the effects of stereochemistry","volume":"6","author":"Chen","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.abb.2021.109077_bib25","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1007\/s00044-012-0386-2","article-title":"Synthesis of d-amino acid peptides and their effect on beta-amyloid aggregation and toxicity in transgenic Caenorhabditis elegans","volume":"22","author":"Jagota","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.abb.2021.109077_bib26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature10154","article-title":"Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation","volume":"475","author":"Sievers","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.abb.2021.109077_bib27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/acschemneuro.9b00419","article-title":"7-Methoxytacrine and 2-aminobenzothiazole heterodimers: structure\u2013mechanism relationship of amyloid inhibitors based on rational design","volume":"11","author":"Gancar","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.abb.2021.109077_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244296","article-title":"Role of surface oxygen-containing functional groups of graphene oxide quantum dots on amyloid fibrillation of two model proteins","volume":"15","author":"Rostampour Ghareghozloo","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.abb.2021.109077_bib29","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1021\/acsomega.8b03169","article-title":"Effect of silica nanoparticles on the amyloid fibrillation of lysozyme","volume":"4","author":"Konar","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.abb.2021.109077_bib30","doi-asserted-by":"crossref","first-page":"15283","DOI":"10.1021\/acs.langmuir.8b02674","article-title":"Graphene oxide quantum dot alters amyloidogenicity of hen egg white lysozyme via modulation of protein surface character","volume":"34","author":"Ban","year":"2018","journal-title":"Langmuir"},{"key":"10.1016\/j.abb.2021.109077_bib31","doi-asserted-by":"crossref","first-page":"14681","DOI":"10.1021\/acs.langmuir.9b02527","article-title":"Mixed carboxyl and hydrophobic dendrimer surface inhibits amyloid-\u03b2 fibrillation: new insight from the generation number effect","volume":"35","author":"Wang","year":"2019","journal-title":"Langmuir"},{"key":"10.1016\/j.abb.2021.109077_bib32","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1021\/acs.biomac.0c00713","article-title":"Small-molecule-functionalized hyperbranched polyglycerol dendrimers for inhibiting protein aggregation","volume":"21","author":"Mandal","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.abb.2021.109077_bib33","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ijbiomac.2017.08.081","article-title":"Deciphering the enhanced inhibitory, disaggregating and cytoprotective potential of promethazine towards amyloid fibrillation","volume":"106","author":"Nusrat","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.abb.2021.109077_bib34","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.ijbiomac.2019.10.137","article-title":"Unravelling the inhibitory and cytoprotective potential of diuretics towards amyloid fibrillation","volume":"150","author":"Malik","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.abb.2021.109077_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1139\/cjpp-2015-0117","article-title":"Inhibition of islet amyloid polypeptide aggregation and associated cytotoxicity by nonsteroidal anti-inflammatory drugs","volume":"94","author":"Fortin","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.abb.2021.109077_bib36","doi-asserted-by":"crossref","DOI":"10.1021\/acs.biomac.0c01802","article-title":"Attenuation of human lysozyme amyloid fibrillation by ACE inhibitor captopril: a combined spectroscopy, microscopy, cytotoxicity, and docking study","author":"Jin","year":"2021","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.abb.2021.109077_bib37","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1021\/acsomega.0c05590","article-title":"Understanding the antibacterial resistance: computational explorations in bacterial membranes","volume":"6","author":"Matamoros-Recio","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.abb.2021.109077_bib38","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1074\/jbc.271.12.6839","article-title":"Inhibition of amyloid \u03b2 protein aggregation and neurotoxicity by rifampicin","volume":"271","author":"Tomiyama","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2021.109077_bib39","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1021\/bp060353n","article-title":"Inhibition of amyloid fibrillization of hen egg-white lysozymes by rifampicin and p-benzoquinone","volume":"23","author":"Lieu","year":"2008","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.abb.2021.109077_bib40","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.chembiol.2004.08.025","article-title":"Rifampicin inhibits \u03b1-synuclein fibrillation and disaggregates fibrils","volume":"11","author":"Li","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.abb.2021.109077_bib41","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/glia.20268","article-title":"Inhibitory effect of minocycline on amyloid beta fibril formation and human microglial activation","volume":"53","author":"Familian","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.abb.2021.109077_bib42","doi-asserted-by":"crossref","first-page":"100943","DOI":"10.1016\/j.bbrep.2021.100943","article-title":"Inhibition of aggregation of amyloid-\u03b2 through covalent modification with benzylpenicillin; potential relevance to Alzheimer's disease","volume":"26","author":"Alsalahat","year":"2021","journal-title":"Biochem. Biophys. Reports."},{"key":"10.1016\/j.abb.2021.109077_bib43","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/glia.22496","article-title":"Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model","volume":"61","author":"Lazzarini","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.abb.2021.109077_bib44","doi-asserted-by":"crossref","first-page":"25929","DOI":"10.1039\/D0RA04949B","article-title":"Bleomycin modulates amyloid aggregation in \u03b2-amyloid and hIAPP","volume":"10","author":"Kumari","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.abb.2021.109077_bib45","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.amjmed.2008.04.039","article-title":"Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates","volume":"121","author":"Johnson","year":"2008","journal-title":"Am. J. Med."},{"key":"10.1016\/j.abb.2021.109077_bib46","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1592\/phco.22.5.395.33185","article-title":"Levofloxacin treatment failure in a patient with fluoroquinolone-resistant Streptococcus pneumoniae pneumonia","volume":"22","author":"Kays","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.abb.2021.109077_bib47","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMoa012122","article-title":"Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia","volume":"346","author":"Davidson","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.abb.2021.109077_bib48","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1086\/323406","article-title":"Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis","volume":"33","author":"Scotton","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.abb.2021.109077_bib49","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jmb.2010.07.005","article-title":"The non-core regions of human lysozyme amyloid fibrils influence cytotoxicity","volume":"402","author":"Mossuto","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.abb.2021.109077_bib50","series-title":"Rayleigh Scattering Technique as a Method to Study Protein \u2013 Protein Interaction Using Spectrofluorimeters","author":"Brahma","year":"2016"},{"key":"10.1016\/j.abb.2021.109077_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12154-009-0027-5","article-title":"Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils-current status","volume":"3","author":"Groenning","year":"2010","journal-title":"J. Chem. Biol."},{"key":"10.1016\/j.abb.2021.109077_bib52","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/prot.23188","article-title":"Prediction of protein secondary structure from circular dichroism using theoretically derived spectra","volume":"80","author":"Louis-Jeune","year":"2012","journal-title":"Proteins Struct. Funct. Bioinforma."},{"key":"10.1016\/j.abb.2021.109077_bib53","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.abb.2021.109077_bib54","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.abb.2021.109077_bib55","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/jcc.20090","article-title":"A biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force-field parameter sets 53A5 and 53A6","volume":"25","author":"Oostenbrink","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.abb.2021.109077_bib56","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.biochem.66.1.385","article-title":"MODELS OF amyloid seeding IN ALZHEIMER\u2019S disease and SCRAPIE:mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins","volume":"66","author":"Harper","year":"1997","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.abb.2021.109077_bib57","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0092-8674(00)80264-0","article-title":"Self-seeded fibers formed by Sup35, the protein determinant of [PSI+], a heritable prion-like factor of S. cerevisiae","volume":"89","author":"Glover","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.abb.2021.109077_bib58","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1006\/jsbi.2000.4264","article-title":"Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants","volume":"130","author":"Morozova-Roche","year":"2000","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.abb.2021.109077_bib59","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biochi.2016.11.002","article-title":"A comparative study of fibrillation kinetics of two homologous proteins under identical solution condition","volume":"132","author":"Chaudhary","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.abb.2021.109077_bib60","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jmb.2008.05.013","article-title":"Prediction of aggregation-prone regions in structured proteins","volume":"380","author":"Tartaglia","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.abb.2021.109077_bib61","doi-asserted-by":"crossref","first-page":"16630","DOI":"10.1039\/C5CP00424A","article-title":"Chelerythrine\u2013lysozyme interaction: spectroscopic studies, thermodynamics and molecular modeling exploration","volume":"17","author":"Jash","year":"2015","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.abb.2021.109077_bib62","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1139\/o11-041","article-title":"Aggregates with lysozyme and ovalbumin show features of amyloid-like fibrils","volume":"89","author":"Sugimoto","year":"2011","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.abb.2021.109077_bib63","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1021\/bi900219c","article-title":"Cellular membrane disruption by amyloid fibrils involved intermolecular disulfide cross-linking","volume":"48","author":"Huang","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2021.109077_bib64","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.redox.2016.12.016","article-title":"Oxidized epigallocatechin gallate inhibited lysozyme fibrillation more strongly than the native form","volume":"11","author":"An","year":"2017","journal-title":"Redox Biol"},{"key":"10.1016\/j.abb.2021.109077_bib65","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/anie.200390319","article-title":"Interactions with aromatic rings in chemical and biological recognition","volume":"42","author":"Meyer","year":"2003","journal-title":"Angew Chem. Int. Ed. Engl."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000398612100326X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000398612100326X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T06:20:03Z","timestamp":1757744403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000398612100326X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":65,"alternative-id":["S000398612100326X"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2021.109077","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition and disruption of amyloid formation by the antibiotic levofloxacin: A new direction for antibiotics in an era of multi-drug resistance","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2021.109077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109077"}}